Does TIOTROPIUM Cause Malignant neoplasm progression? 23 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 23 reports of Malignant neoplasm progression have been filed in association with TIOTROPIUM (Tiotropium Bromide). This represents 0.1% of all adverse event reports for TIOTROPIUM.
23
Reports of Malignant neoplasm progression with TIOTROPIUM
0.1%
of all TIOTROPIUM reports
16
Deaths
6
Hospitalizations
How Dangerous Is Malignant neoplasm progression From TIOTROPIUM?
Of the 23 reports, 16 (69.6%) resulted in death, 6 (26.1%) required hospitalization.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TIOTROPIUM. However, 23 reports have been filed with the FAERS database.
What Other Side Effects Does TIOTROPIUM Cause?
Dyspnoea (10,863)
Incorrect route of drug administration (9,079)
Asthma (7,944)
Wheezing (5,361)
Therapeutic product effect incomplete (4,327)
Cough (4,202)
Product quality issue (3,821)
Drug ineffective (3,642)
Loss of personal independence in daily activities (3,414)
Pneumonia (3,046)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which TIOTROPIUM Alternatives Have Lower Malignant neoplasm progression Risk?
TIOTROPIUM vs TIPIRACIL\TRIFLURIDINE
TIOTROPIUM vs TIPRANAVIR
TIOTROPIUM vs TIRAGOLUMAB
TIOTROPIUM vs TIRBANIBULIN
TIOTROPIUM vs TIROFIBAN